By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According to news reporting originating from Bethesda, Maryland, by NewsRx correspondents, research stated, “We evaluated human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) administration at the Walter Reed National Military Medical Center (WRNMMC), which serves a geographic area at high risk of HIV infection. Medical records were reviewed for all patients initiating PrEP at WRNMMC from November 1, 2013, to March 30, 2016.”

Financial supporters for this research include U.S. Army Medical Research and Materiel Command, U.S. Department of Defense.

Our news editors obtained a quote from the research from Walter Reed National Military Medical Center, “Demographic, laboratory, clinical, and risk exposure characteristics and outcomes were described. One hundred fifty-nine patients received PrEP; 133 (84%) patients were active duty, 95 (60%) patients were over 28 yr old. The majority were non-Hispanic Whites (n = 87, 55%). The median men who have sex with men (MSM) risk index score was 18.0 (IQR 12.0-22.0); 20 patients scored less than 10. One hundred and thirty-one (82%) patients remained on PrEP through the evaluation period. Patients mainly discontinued PrEP for service-related or toxicity reasons. Incident STIs occurred in 31 (19%) patients. No cases of HIV seroconversion were observed. In this first description of PrEP utilization in a U.S. military health care system, a significant number of patients were non-Hispanic Whites, well-educated, were older, or were otherwise at low risk for HIV acquisition.”

According to the news editors, the research concluded: “Further effort is needed to enhance PrEP use among the higher risk young African-American MSM population, and further studies are needed to determine the cost-effectiveness of PrEP in individuals who are not categorized as high risk.”

For more information on this research see: HIV PrEP in the Military: Experience at a Tertiary Care Military Medical Center. Military Medicine , 2018;183():445-449. Military Medicine can be contacted at: Oxford Univ Press, Great Clarendon St, Oxford OX2 6DP, England.

The news editors report that additional information may be obtained by contacting J.M. Blaylock, Walter Reed Natl Military Med Center, Infect Dis Serv, Bethesda, MD 20889, United States. Additional authors for this research include S. Hakre, C.F. Decker, B. Wilson, E. Bianchi, N. Michael, C. Beckett, J. Okulicz and P.T. Scott.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1093/milmed/usx143. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

CITATION: (2018-05-08), Researchers from Walter Reed National Military Medical Center Describe Findings in HIV/AIDS (HIV PrEP in the Military: Experience at a Tertiary Care Military Medical Center), Life Science Weekly, 4302, ISSN: 1552-2474, BUTTER® ID: 015616411

From the newsletter Life Science Weekly.
https://www.newsrx.com/Butter/#!Search:a=15616411

This is a NewsRx^® article created by NewsRx^® and posted by NewsRx^®. As proof that we are NewsRx^® posting NewsRx^® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.

We have been in business for more than 20 years and our full contact information is available on our main corporate website.

We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.

NewsRx^® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.

View Newsletter Titles

About NewsRx^® and Contact Information

Topics